Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07276867 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intrathecal Dexmedetomidine-Fentanyl Combination Versus Fentanyl Alone as Adjuvant to Bupivacaine in Spinal Anesthesia for Above Knee Amputation in Sarcomas of Lower Extremity

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 11, 2025 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The current work evaluated whether the combination of intrathecal dexmedetomidine and fentanyl provides superior postoperative analgesia to fentanyl alone when administered with hyperbaric bupivacaine.
Trial Details
NCT Number NCT07276867
Lead Sponsor National Cancer Institute, Egypt
Conditions
(from sponsor)		 Intrathecal, Dexmedetomidine, Fentanyl, Bupivacaine, Spinal Anesthesia, Above Knee Amputation, Sarcomas, Lower Extremity
Related terms Sarcoma
Enrollment 58 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov